Industry News

FDA Warns Hospira Again, This Time in India

June 5, 2013

Hospira has received another warning letter from the US FDA following an inspection at the company’s India plant in October 2012. Read the full story

Latest from Industry News

Sartorius Stedim, Nanotein partner to advance immune cell manufacturing

WuXi Biologics launches stable cell line platform for development, manufacturing

Excellos, Lonza, Akadeum team to advance cell therapy manufacturing

Sumitomo’s CDMO to double regenerative medicine manufacturing capacity